Actively Recruiting
Efficacy and Safety of Telmisartan Compared With Losartan
Led by Chong Kun Dang Pharmaceutical · Updated on 2024-05-28
98
Participants Needed
1
Research Sites
132 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A study to evaluate the efficacy and safety of telmisartan compared with losartan in patients with diabetic nephropathy and hypertension
CONDITIONS
Official Title
Efficacy and Safety of Telmisartan Compared With Losartan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female subjects aged 19 to less than 75 years
- Subjects with type II diabetes mellitus who have been taking medication
- Subjects who voluntarily consented and signed the informed consent form
You will not qualify if you...
- Subjects with type I diabetes mellitus
- Subjects with primary hyper-aldosteronism
- Subjects with a history or suspicion of drug or alcohol abuse within 1 year before screening
- Pregnant or lactating women or those unwilling to use contraception during the study
- Subjects who received other clinical trial drugs within 28 days before screening
- Subjects deemed unable to participate by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Severance Hospital
Seoul, South Korea
Actively Recruiting
Research Team
B
BeomSeok Kim, M.D, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here